FDA Watch: 23andMe Continues to Spearhead Direct-to-Consumer Marketing of LDT Genetic Tests
From - Laboratory Industry Report On March 6, the FDA announced its first ever approval of a direct-to-consumer breast cancer gene test… . . . read more
This content is exclusive to Lab Industry Report subscribers
Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.